What happened in health tech today? 213 stories made the cut. Funding rounds, regulatory moves, product launches, and the deals behind them.
AI in Healthcare
Telehealth & Virtual Care
Wearables & Remote Monitoring
Health IT & Security
The Next Competitive Advantage in Drug Development Won’t Be a Better Molecule. It’ll Be Better Patient Selection.
For decades, the industry has organized itself around a single question: how do we discover more, and better, drug candidates? Target identification keeps getting smarter, molecule generation keeps getting faster, and AI has now touched nearly every stage of early discovery. Yet a molecule is only ever as good as the patients it happens to ... Read More
ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs
How Experts Are Reacting to Trump’s Women’s Health Executive Order
Women’s health experts had mixed reactions to the Trump administration’s executive order on women’s health. The post How Experts Are Reacting to Trump’s Women’s Health Executive Order appeared first on MedCity News.
Policy & Regulation
STAT+: HHS relaxes security, transparency rules for health record software used by hospitals
The Trump administration removed several security, privacy and transparency requirements for vendors of EHR software.
Funding & Deals
Obesity Biotech Corxel Is Going Public in a Merger as Oral GLP-1 Heads to Phase 3
Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule could offer better tolerability compared to the rest of its class. The SPAC merger taking Corxel public is expected to close in the first half of 2027, which is when the biotech plans to start a Phase 3 trial. The post Obesity Biotech Corxel Is Going Public in a Merger as Ora…